Related Experiment Video
Updated: Jun 21, 2026

Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
Published on: November 8, 2024
The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats
1Center for Research on Drug Dependence, Department of Psychology, Concordia University, Sir George Williams Campus, Montreal, Quebec H3G 1M8, Canada.
Abstract:
Two groups of ethanol-drinking rats were subjected to differential treatments with 6-hydroxydopamine in order to selectively destroy norepinephrine- and dopamine-containing neurons in the brain. Animals with extensive depletions of norepinephrine and dopamine produced by treatment with pargyline prior to 6-hydroxydopamine infusions showed a significant attenuation of preference for alcohol. However, where norepinephrine neurons were protected from the neurotoxic effects of 6-hydroxydopamine by pretreatment with desmethylimipramine, the consequent effects on ethanol preference were not significant. It was suggested that catecholamines are involved in the mediation of ethanol self-administration with norepinephrine possibly playing the dominant role.
More Related Videos
07:50A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
CNS Depressants: Alcohol and Nicotine
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting Neurotransmitter Release or Uptake